These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 8750363)

  • 41. Bioequivalence of soft gelatin capsules and oral solution of a new cyclosporine formulation.
    Kovarik JM; Mueller EA; Johnston A; Hitzenberger G; Kutz K
    Pharmacotherapy; 1993; 13(6):613-7. PubMed ID: 8302687
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Evidence of different pharmacokinetics including relationship among AUC, peak, and trough levels between cyclosporine and tacrolimus in renal transplant recipients using new pharmacokinetic parameter--why cyclosporine is monitored by C(2) level and tacrolimus by trough level--.
    Takeuchi H; Matsuno N; Senuma K; Hirano T; Yokoyama T; Taira S; Kihara Y; Kuzuoka K; Konno O; Jojima Y; Mejit A; Akashi I; Nakamura Y; Iwamoto H; Hama K; Iwahori T; Ashizawa T; Nagao T; Toraishi T; Okuyama K; Oka K; Unezaki S
    Biol Pharm Bull; 2008 Jan; 31(1):90-4. PubMed ID: 18175948
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Evaluation of the bioequivalence of single 100-mg doses of two oral formulations of cyclosporin A microemulsion: a randomized, open-label, two-period crossover study in healthy adult male Mexican volunteers.
    Piñeyro-López A; Piñeyro-Garza E; Torres-Alanís O; Reyes-Araiza R; Gómez-Silva M; Waksman N; E Salazar-Leal M; Luján-Rangel R
    Clin Ther; 2007 Sep; 29(9):2049-54. PubMed ID: 18035203
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Relative bioavailability of single doses of prolonged-release tacrolimus administered as a suspension, orally or via a nasogastric tube, compared with intact capsules: a phase 1 study in healthy participants.
    Undre N; Dickinson J
    BMJ Open; 2017 Apr; 7(4):e012252. PubMed ID: 28377389
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A randomized pilot study of cyclosporin G in renal transplantation.
    Ohlman S; Lindholm A; Gäbel H; Wilczek H; Tydén G; Reinholt F; Säwe J; Groth CG
    Transpl Int; 1992; 5 Suppl 1():S464-9. PubMed ID: 14621848
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Testing switchability of a new microemulsion formulation of cyclosporine.
    Talaulikar GS; Srishyla MV; Job V; Selvakumar R; Thomas PP
    Transplant Proc; 2003 Dec; 35(8):2899-901. PubMed ID: 14697932
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Optimal dose and target trough level in cyclosporine and tacrolimus conversion in renal transplantation as evaluated by lymphocyte drug sensitivity and pharmacokinetic parameters.
    Takeuchi H; Okuyama K; Konno O; Jojima Y; Akashi I; Nakamura Y; Iwamoto H; Hama K; Iwahori T; Uchiyama M; Ashizawa T; Matsuno N; Nagao T; Hirano T; Oka K
    Transplant Proc; 2005 May; 37(4):1745-7. PubMed ID: 15919452
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Improved dose linearity of cyclosporine pharmacokinetics from a microemulsion formulation.
    Mueller EA; Kovarik JM; van Bree JB; Tetzloff W; Grevel J; Kutz K
    Pharm Res; 1994 Feb; 11(2):301-4. PubMed ID: 8165192
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Oral cyclosporine preparations immediately following renal transplantation.
    Katz SM; Amante A; Schoenberg L; Kahan BD
    Transplant Proc; 1996 Aug; 28(4):2164. PubMed ID: 8769188
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Long-term changes in cyclosporine pharmacokinetics after renal transplantation in children: evidence for saturable presystemic metabolism and effect of NR1I2 polymorphism.
    Fanta S; Jönsson S; Karlsson MO; Niemi M; Holmberg C; Hoppu K; Backman JT
    J Clin Pharmacol; 2010 May; 50(5):581-97. PubMed ID: 20107201
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Cyclosporine bioavailability of two physically different oral formulations.
    Postolache P; Petrescu O; Dorneanu V; Zanini AC
    Eur Rev Med Pharmacol Sci; 2002; 6(6):127-31. PubMed ID: 12776806
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Variable oral absorption of cyclosporine. A biopharmaceutical risk factor for chronic renal allograft rejection.
    Kahan BD; Welsh M; Schoenberg L; Rutzky LP; Katz SM; Urbauer DL; Van Buren CT
    Transplantation; 1996 Sep; 62(5):599-606. PubMed ID: 8830822
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Comparison of cyclosporine concentrations 2 hours post-dose determined using 3 different methods and trough level in pediatric renal transplantation.
    Rodríguez E; Delucchi MA; Cano F; Valdebenito S; Castillo MC; Villegas R
    Transplant Proc; 2005 Oct; 37(8):3354-7. PubMed ID: 16298594
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Pharmacokinetic profile and variability of cyclosporine versus neoral in patients with cystic fibrosis after lung transplantation.
    Kesten S; Scavuzzo M; Chaparro C; Szalai JP
    Pharmacotherapy; 1998; 18(4):847-50. PubMed ID: 9692659
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Pre- and postrenal transplantation pharmacokinetics of cyclosporine microemulsion.
    Talaulikar GS; John GT; Selvakumar R; Job V; Thomas PP; Jacob CK
    Transplant Proc; 2003 Jun; 35(4):1295-7. PubMed ID: 12826141
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Pharmacokinetics of a new oral formulation of cyclosporine in liver transplant recipients.
    Freeman D; Grant D; Levy G; Rochon J; Wong PY; Altraif I; Asfar S
    Ther Drug Monit; 1995 Jun; 17(3):213-6. PubMed ID: 7624915
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Pharmacokinetics of cyclosporine a conversion from twice-daily infusion to oral administration in allogeneic hematopoietic stem cell transplantation.
    Inoue Y; Saito T; Ogawa K; Nishio Y; Kosugi S; Suzuki Y; Kato M; Sakai H; Takahashi M; Miura I
    Am J Ther; 2014; 21(5):377-84. PubMed ID: 23011175
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Cyclosporine microemulsion increases drug exposure and reduces acute rejection without incremental toxicity in de novo renal transplantation. International Sandimmun Neoral Study Group.
    Keown P; Niese D
    Kidney Int; 1998 Sep; 54(3):938-44. PubMed ID: 9734620
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Impact of early cyclosporin average blood concentration on early kidney transplant failure.
    Senel MF; Van Buren CT; Welsh M; Kahan BD
    Transpl Int; 1998; 11(1):46-52. PubMed ID: 9503554
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Comparative pharmacokinetics and renal effects of cyclosporin A and cyclosporin G in renal allograft recipients.
    Gruber SA; Gallichio M; Rosano TG; Kaplan SS; Hughes SE; Urbauer DL; Singh TP; Lempert N; Conti DJ; Stein DS; Drusano G
    J Clin Pharmacol; 1997 Jul; 37(7):575-86. PubMed ID: 9243350
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.